Your browser doesn't support javascript.
loading
Predictive biomarkers of response to immune checkpoint inhibitors in hepatocellular carcinoma.
Muhammed, Ambreen; D'Alessio, Antonio; Enica, Andrei; Talbot, Thomas; Fulgenzi, Claudia Angela Maria; Nteliopoulos, Georgios; Goldin, Robert D; Cortellini, Alessio; Pinato, David J.
Afiliación
  • Muhammed A; Department of Surgery & Cancer, Imperial College London, London, UK.
  • D'Alessio A; Department of Surgery & Cancer, Imperial College London, London, UK.
  • Enica A; Department of Biomedical Sciences, Humanitas University, Rozzano, Italy.
  • Talbot T; Department of Surgery & Cancer, Imperial College London, London, UK.
  • Fulgenzi CAM; Department of Surgery & Cancer, Imperial College London, London, UK.
  • Nteliopoulos G; Department of Surgery & Cancer, Imperial College London, London, UK.
  • Goldin RD; Division of Medical Oncology, Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • Cortellini A; Department of Surgery & Cancer, Imperial College London, London, UK.
  • Pinato DJ; Department of Surgery & Cancer, Imperial College London, London, UK.
Expert Rev Mol Diagn ; 22(3): 253-264, 2022 03.
Article en En | MEDLINE | ID: mdl-35236211
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Expert Rev Mol Diagn Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Expert Rev Mol Diagn Asunto de la revista: BIOLOGIA MOLECULAR Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido